Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nuclear Physics | 6 | 2014 | 73 | 0.650 |
Why?
|
Elementary Particles | 4 | 2014 | 50 | 0.440 |
Why?
|
Myeloproliferative Disorders | 4 | 2015 | 616 | 0.420 |
Why?
|
Chromosome Aberrations | 4 | 2013 | 1776 | 0.400 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 2 | 2023 | 172 | 0.380 |
Why?
|
Decidua | 1 | 2011 | 82 | 0.360 |
Why?
|
Hormone Replacement Therapy | 1 | 2016 | 756 | 0.350 |
Why?
|
Abortion, Habitual | 1 | 2011 | 63 | 0.350 |
Why?
|
Cesarean Section, Repeat | 1 | 2009 | 32 | 0.320 |
Why?
|
Receptors, Progesterone | 1 | 2013 | 1159 | 0.310 |
Why?
|
Calreticulin | 3 | 2014 | 115 | 0.310 |
Why?
|
Thrombocythemia, Essential | 3 | 2014 | 114 | 0.300 |
Why?
|
Arsenic | 1 | 2012 | 357 | 0.300 |
Why?
|
Water Pollutants, Chemical | 1 | 2012 | 356 | 0.290 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2024 | 3626 | 0.280 |
Why?
|
Models, Theoretical | 6 | 2014 | 3561 | 0.280 |
Why?
|
Receptors, Estrogen | 2 | 2022 | 2252 | 0.270 |
Why?
|
Placenta Diseases | 1 | 2009 | 199 | 0.270 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2011 | 523 | 0.270 |
Why?
|
Neuroblastoma | 4 | 2022 | 1266 | 0.250 |
Why?
|
Primary Myelofibrosis | 4 | 2014 | 208 | 0.240 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1061 | 0.230 |
Why?
|
Hypereosinophilic Syndrome | 2 | 2015 | 97 | 0.220 |
Why?
|
Elementary Particle Interactions | 2 | 2013 | 17 | 0.220 |
Why?
|
Janus Kinase 2 | 4 | 2014 | 561 | 0.210 |
Why?
|
Receptor, erbB-2 | 1 | 2013 | 2599 | 0.210 |
Why?
|
Barth Syndrome | 1 | 2022 | 25 | 0.200 |
Why?
|
Killer Cells, Natural | 1 | 2011 | 2209 | 0.190 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3828 | 0.180 |
Why?
|
Acyltransferases | 1 | 2022 | 305 | 0.170 |
Why?
|
Registries | 2 | 2017 | 8351 | 0.170 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 384 | 0.170 |
Why?
|
Neutrophils | 2 | 2023 | 3779 | 0.170 |
Why?
|
Candidiasis | 1 | 2022 | 366 | 0.160 |
Why?
|
Toll-Like Receptors | 1 | 2022 | 582 | 0.150 |
Why?
|
Receptors, Thrombopoietin | 3 | 2013 | 159 | 0.140 |
Why?
|
DNA Replication | 1 | 2024 | 1426 | 0.140 |
Why?
|
Mesons | 2 | 2014 | 28 | 0.140 |
Why?
|
Neutropenia | 1 | 2022 | 892 | 0.140 |
Why?
|
Myositis Ossificans | 1 | 2017 | 77 | 0.130 |
Why?
|
Leukemia | 2 | 2022 | 1518 | 0.130 |
Why?
|
Oncogenes | 1 | 2022 | 1232 | 0.130 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2015 | 1608 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-cbl | 2 | 2013 | 120 | 0.130 |
Why?
|
DNA Modification Methylases | 1 | 2015 | 207 | 0.120 |
Why?
|
Ossification, Heterotopic | 1 | 2017 | 240 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2013 | 2843 | 0.120 |
Why?
|
Neutrons | 1 | 2014 | 78 | 0.110 |
Why?
|
Proteins | 2 | 2023 | 6001 | 0.110 |
Why?
|
DNA Repair Enzymes | 1 | 2015 | 342 | 0.110 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4903 | 0.110 |
Why?
|
Genome | 1 | 2022 | 1752 | 0.110 |
Why?
|
Pyrazoles | 2 | 2015 | 2028 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 2 | 2015 | 2800 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2013 | 2902 | 0.100 |
Why?
|
Uniparental Disomy | 1 | 2012 | 46 | 0.100 |
Why?
|
Serbia | 1 | 2012 | 13 | 0.100 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2013 | 411 | 0.100 |
Why?
|
Ultrasonography, Prenatal | 2 | 2010 | 1772 | 0.090 |
Why?
|
Nucleotides | 2 | 2024 | 454 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2013 | 4522 | 0.090 |
Why?
|
Water Supply | 1 | 2012 | 204 | 0.090 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2011 | 370 | 0.090 |
Why?
|
Multicystic Dysplastic Kidney | 1 | 2010 | 7 | 0.090 |
Why?
|
Karyotyping | 1 | 2012 | 1176 | 0.090 |
Why?
|
Dioxygenases | 1 | 2012 | 353 | 0.090 |
Why?
|
Loss of Heterozygosity | 1 | 2012 | 663 | 0.090 |
Why?
|
beta-Thalassemia | 1 | 2012 | 234 | 0.080 |
Why?
|
Umbilical Arteries | 1 | 2010 | 77 | 0.080 |
Why?
|
Kell Blood-Group System | 1 | 2009 | 21 | 0.080 |
Why?
|
Aromatase Inhibitors | 1 | 2013 | 519 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3667 | 0.080 |
Why?
|
Erythroblastosis, Fetal | 1 | 2009 | 62 | 0.080 |
Why?
|
Mutation | 4 | 2014 | 30211 | 0.080 |
Why?
|
Cytomegalovirus | 1 | 2013 | 751 | 0.080 |
Why?
|
Blood Group Incompatibility | 1 | 2009 | 134 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3530 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2015 | 8628 | 0.080 |
Why?
|
Cell Cycle | 2 | 2013 | 2927 | 0.080 |
Why?
|
Humans | 32 | 2024 | 767040 | 0.080 |
Why?
|
Menopause | 1 | 2016 | 1655 | 0.070 |
Why?
|
Mice | 11 | 2024 | 81912 | 0.070 |
Why?
|
RNA Splicing | 1 | 2012 | 903 | 0.070 |
Why?
|
Abruptio Placentae | 1 | 2009 | 116 | 0.070 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 771 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12250 | 0.070 |
Why?
|
Protons | 1 | 2013 | 1101 | 0.070 |
Why?
|
Placenta Previa | 1 | 2009 | 125 | 0.070 |
Why?
|
DNA-Binding Proteins | 3 | 2013 | 9612 | 0.070 |
Why?
|
Fagopyrum | 1 | 2006 | 1 | 0.070 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1058 | 0.070 |
Why?
|
Signal Transduction | 3 | 2024 | 23621 | 0.070 |
Why?
|
Pregnancy | 6 | 2011 | 30238 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3797 | 0.070 |
Why?
|
Chromosome Deletion | 1 | 2011 | 1384 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2013 | 836 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3253 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11657 | 0.070 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 951 | 0.070 |
Why?
|
Breast Neoplasms | 1 | 2013 | 21178 | 0.060 |
Why?
|
Fertility | 1 | 2011 | 771 | 0.060 |
Why?
|
Fetal Growth Retardation | 1 | 2010 | 592 | 0.060 |
Why?
|
Neoplasm Proteins | 2 | 2022 | 3599 | 0.060 |
Why?
|
Female | 18 | 2021 | 396660 | 0.060 |
Why?
|
Placenta Accreta | 1 | 2009 | 242 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6513 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 2 | 2013 | 1399 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2013 | 1536 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 1244 | 0.060 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 1752 | 0.060 |
Why?
|
Repressor Proteins | 2 | 2012 | 2979 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5332 | 0.060 |
Why?
|
Transcription Factors | 4 | 2022 | 12158 | 0.060 |
Why?
|
Exons | 3 | 2014 | 2391 | 0.050 |
Why?
|
Animals | 11 | 2024 | 168965 | 0.050 |
Why?
|
S Phase | 1 | 2024 | 424 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2887 | 0.050 |
Why?
|
Cardiolipins | 1 | 2022 | 82 | 0.050 |
Why?
|
Apoptosis | 2 | 2022 | 9513 | 0.050 |
Why?
|
Polycythemia Vera | 2 | 2013 | 160 | 0.050 |
Why?
|
Disease Progression | 3 | 2017 | 13646 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3440 | 0.050 |
Why?
|
Partial Pressure | 1 | 2021 | 247 | 0.050 |
Why?
|
Ultraviolet Rays | 1 | 2006 | 1101 | 0.050 |
Why?
|
Cell Degranulation | 1 | 2022 | 276 | 0.050 |
Why?
|
Oxidoreductases | 1 | 2023 | 409 | 0.050 |
Why?
|
Gases | 1 | 2021 | 205 | 0.050 |
Why?
|
Mice, Congenic | 1 | 2020 | 98 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9532 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 17097 | 0.040 |
Why?
|
Histone Acetyltransferases | 1 | 2022 | 333 | 0.040 |
Why?
|
Gene Library | 1 | 2022 | 1065 | 0.040 |
Why?
|
Prognosis | 3 | 2022 | 29963 | 0.040 |
Why?
|
Leukemia, Myeloid | 2 | 2013 | 693 | 0.040 |
Why?
|
Nitriles | 2 | 2015 | 980 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4401 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7435 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12069 | 0.040 |
Why?
|
Candida albicans | 1 | 2022 | 376 | 0.040 |
Why?
|
Antioxidants | 1 | 2006 | 1671 | 0.040 |
Why?
|
Cell Count | 1 | 2022 | 1825 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7210 | 0.040 |
Why?
|
Transgenes | 1 | 2022 | 1014 | 0.040 |
Why?
|
Remission Induction | 2 | 2015 | 2408 | 0.040 |
Why?
|
Nuclear Proteins | 3 | 2022 | 5794 | 0.040 |
Why?
|
Pyrimidines | 3 | 2015 | 3044 | 0.040 |
Why?
|
Animals, Genetically Modified | 1 | 2022 | 1562 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13650 | 0.030 |
Why?
|
Base Sequence | 2 | 2022 | 12414 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2012 | 10455 | 0.030 |
Why?
|
Mice, Nude | 2 | 2013 | 3618 | 0.030 |
Why?
|
Phagocytosis | 1 | 2022 | 1526 | 0.030 |
Why?
|
Glucose-6-Phosphate Isomerase | 1 | 2015 | 49 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1837 | 0.030 |
Why?
|
Benzeneacetamides | 1 | 2015 | 36 | 0.030 |
Why?
|
Pyrans | 1 | 2015 | 47 | 0.030 |
Why?
|
Cell Lineage | 1 | 2024 | 2575 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2040 | 0.030 |
Why?
|
Adult | 7 | 2017 | 223317 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2013 | 6067 | 0.030 |
Why?
|
Aged | 6 | 2021 | 171319 | 0.030 |
Why?
|
Thrombocytosis | 1 | 2013 | 88 | 0.030 |
Why?
|
Vincristine | 1 | 2015 | 1040 | 0.030 |
Why?
|
Veratrum Alkaloids | 1 | 2012 | 23 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2023 | 3726 | 0.030 |
Why?
|
Sulfones | 1 | 2015 | 447 | 0.030 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2015 | 296 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12790 | 0.030 |
Why?
|
Electrons | 1 | 2014 | 264 | 0.030 |
Why?
|
Dacarbazine | 1 | 2015 | 552 | 0.030 |
Why?
|
Ganciclovir | 1 | 2013 | 256 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 16036 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 581 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 1647 | 0.030 |
Why?
|
Pyridines | 2 | 2015 | 2890 | 0.020 |
Why?
|
Camptothecin | 1 | 2015 | 599 | 0.020 |
Why?
|
Codon | 1 | 2013 | 599 | 0.020 |
Why?
|
Janus Kinases | 1 | 2013 | 253 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2012 | 0.020 |
Why?
|
Granulocytes | 1 | 2013 | 551 | 0.020 |
Why?
|
Bone Marrow Diseases | 1 | 2013 | 234 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4780 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2015 | 723 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 713 | 0.020 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 308 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26325 | 0.020 |
Why?
|
beta Catenin | 1 | 2015 | 1048 | 0.020 |
Why?
|
Medulloblastoma | 1 | 2015 | 682 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2021 | 2745 | 0.020 |
Why?
|
Triazoles | 1 | 2015 | 903 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2980 | 0.020 |
Why?
|
Fetal Monitoring | 1 | 2010 | 69 | 0.020 |
Why?
|
Oxygen | 1 | 2021 | 4252 | 0.020 |
Why?
|
Pyrazines | 1 | 2015 | 1204 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2022 | 3076 | 0.020 |
Why?
|
Thrombosis | 2 | 2013 | 2954 | 0.020 |
Why?
|
Cisplatin | 1 | 2015 | 1656 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3944 | 0.020 |
Why?
|
Male | 7 | 2021 | 364203 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9551 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 699 | 0.020 |
Why?
|
Doxorubicin | 1 | 2015 | 2229 | 0.020 |
Why?
|
Random Allocation | 1 | 2013 | 2394 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2012 | 715 | 0.020 |
Why?
|
Middle Aged | 4 | 2021 | 223233 | 0.020 |
Why?
|
Genotype | 2 | 2014 | 13035 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2013 | 1141 | 0.020 |
Why?
|
Gene Amplification | 1 | 2012 | 1088 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2023 | 14476 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2010 | 463 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2013 | 1391 | 0.020 |
Why?
|
DNA, Plant | 1 | 2006 | 51 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2013 | 26396 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22350 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4670 | 0.020 |
Why?
|
Catalase | 1 | 2006 | 215 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2010 | 1479 | 0.020 |
Why?
|
Plant Leaves | 1 | 2006 | 153 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4539 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10254 | 0.020 |
Why?
|
Lipid Peroxidation | 1 | 2006 | 276 | 0.020 |
Why?
|
Glycoproteins | 1 | 2013 | 2200 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4114 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4572 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2015 | 5891 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5022 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3608 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 596 | 0.010 |
Why?
|
Young Adult | 3 | 2017 | 59980 | 0.010 |
Why?
|
Peroxidase | 1 | 2006 | 610 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2011 | 4616 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3427 | 0.010 |
Why?
|
Infant | 2 | 2017 | 36485 | 0.010 |
Why?
|
Antigens, CD | 1 | 2013 | 4032 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2022 | 18330 | 0.010 |
Why?
|
Child, Preschool | 2 | 2017 | 42606 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6893 | 0.010 |
Why?
|
Adolescent | 3 | 2017 | 89046 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11063 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2013 | 2212 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22361 | 0.010 |
Why?
|
Peptides | 1 | 2013 | 4348 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7236 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2013 | 3070 | 0.010 |
Why?
|
Glioma | 1 | 2015 | 3502 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13485 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17608 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15567 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12536 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2011 | 4925 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9362 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12793 | 0.010 |
Why?
|
Child | 2 | 2017 | 80771 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54886 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15851 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16718 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6966 | 0.010 |
Why?
|
Kidney | 1 | 2010 | 7063 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9108 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 18063 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 65295 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2013 | 59548 | 0.000 |
Why?
|